Pharmacy Law & Ethics & Pharmaceutical Jurisprudence | Pharmacy Law And Ethics DPEE Noteskarts

Pharmacy Law & Ethics & Pharmaceutical Jurisprudence | Pharmacy Law and Ethics DPEE

This test is Improve for Pharmacy exam like Diploma in Pharmacy exit exam MCQs (DPEE), GPAT, & other competitive exam. Pharmacy Law & Ethics Class Test | Pharmacy Law & Ethics DPEE Test

Top 50 Question for Pharmacy Law & Ethics & Pharmaceutical Jurisprudence | Pharmacy Law and Ethics DPEE

358

1 / 50

1. For schedule X drug use of Human beings special labeling requirement require is

a. Symbol N displayed on left top corner of the label.

b. Symbol X given in red

c. Symbol N is red displayed on left top corner of the label

d. Symbol H displayed on right top corner of the label.

2 / 50

2. If blood group is “AB” then colour label used is

a. Blue

b. Yellow

c. Red

d. White

3 / 50

3. For parenteral preparation in glass containers minimum area required is

a. 150 square meters

b. 400 square meters

c. 500 square meters

d. 250 square meters

4 / 50

4. Kala jadu or Kavach comes under

a. Schedule J

b. Schedule K

c. Schedule L

d. Schedule P

5 / 50

5. List of drugs which should be used by patient under medical supervision is covered under………..as per D & C Act.

a. Schedule G

b. Schedule H

c. Schedule I

d. Schedule J

6 / 50

6. In Phase-2 trial following number of patient should be studied

a. 100 patients

b. 10-12 patients

c. 1-10 patients

d. 500 patients

7 / 50

7. If drug is so colored, coated or polished that damage its therapeutic value or it is made to appear of better or greater therapeutic value than it really is known as

a. Adulterated Drug

b. Misbranded Drug

c. True Drug

d. Spurious Drug

8 / 50

8. Example of Schedule G drug is

a. Metformin

b. Barbital

c. Enalapril

d. Cefuroxime

9 / 50

9. Dettol comes under

a. Schedule O

b. Schedule N

c. Schedule Q

d. Schedule P

10 / 50

10. TGA is regulatory agency of………….

a. India

b. Denmark

c. Zimbabwe

d. Australia

11 / 50

11. The Education Regulation (ER) is published in official gazette by

a. Ministry of Education

b. Central Government

c. Drug Controller

d. President, Pharmacy Council of India

12 / 50

12. Pharmacy Council of India contain comprises…….. Members (s) from AICTE and UGC.

a. 1

b. 4

c. 2

d. 3

13 / 50

13. One of the following is/all ex officio member(s) of State Pharmacy Council

a. Assistant drug controller

b. Chief pharmacist of government hospital

c. Chief administrative medical officer of the state

d. All

14 / 50

14. Schedule X of Drugs and Cosmetics Act comprises

a. Guidelines for clinical Trials

b. List of generic drugs

c. List of incurable diseases

d. None of the above

15 / 50

15. DTAB has ———————– ex officio members

a. Eight

b. Five

c. Six

d. Four

16 / 50

16. MHRA is regulatory agency of ……….....

a. UK

b. Brazil

c. South Africa

d. Denmark

17 / 50

17. Biological and Biotechnological products are included in schedule.

a. B

b. X

c. C and C1

d. A

18 / 50

18. As per D and C act schedule T stated about

a. Requirements of factory premises for the manufacturer of Allopathy drugs

b. Requirements of factory premises for the manufacture of Medical device

c. Requirements of factory premises for the manufacturer of Homeopathy drugs

d. Requirements of factory premises for the manufacturer of Ayurveda, Sidhha and Unani drugs

19 / 50

19. In State Pharmacy Council all following are ex officio members except.

a. The officer in charge of drugs control organization

b. Chief Administrator medical officer of state

c. President of India

d. Government Analyst

20 / 50

20. Drug and Magic Remedies Act is enacted in

a. 1919

b. 1948

c. 1985

d. 1954

21 / 50

21. As per D and C Act “Schedule N” is related with

a. Area required to open wholesale drug store

b. List of maximum equipments for efficiently running pharmacy

c. Area for opening retail pharmacy

d. List of minimum equipments for efficiently running pharmacy

22 / 50

22. Grant of licence to manufacture a drug requires.

a. Form 27

b. Form 26

c. Form 24

d. Form 25

23 / 50

23. Patent Act is established in

a. 1970

b. 1919

c. 1940

d. 1948

24 / 50

24. Pharmacy Council of India (PCI) is reconstituted:

a. Every 5 year

b. Every 6 year

c. Every 2 year

d. Every 3 year

25 / 50

25. Schedule…………… of Drugs and Cosmetics Act in Cludes requirements and guidelines on clinical trials for import and manufacturing of new drugs.

a. W

b. V

c. X

d. Y

26 / 50

26. State Pharmacy Council should have the following number of elected members.

a. Five

b. Nine

c. Six

d. Seven

27 / 50

27. Schedule C is related to

a. List of Homeopathy product

b. List of Ayurvedic product

c. List of Biological and Immunological product

d. List of Allopathic product

28 / 50

28. List of drugs whole import, manufacture and sale, labeling and packaging are governed by special provisions are included in schedule.

a. K

b. H

c. X

d. G

29 / 50

29. Hatch Waxman Act is related to

a. Dangerous drugs Act

b. Over the counter drugs

c. Banned drugs

d. Spurious drugs Act

30 / 50

30. Schedule N states

a. List of minimum equipment for efficient running of pharmacy

b. List of minimum equipment required for manufacturing of drug.

c. Requirement of factory premises and hygienic condition to complied

d. Standard for cosmetics

31 / 50

31. In 1954 one of the following act is passed

a. Narcotic and psychotropic substance Act

b. The Medical Termination of pregnancy Act

c. Poisonous Act.

d. Drug and magic Remedies Act

32 / 50

32. List of coal tar colours permitted to be used in cosmetics is covered under.

a. Schedule O

b. Schedule Q

c. Schedule P

d. Schedule R

33 / 50

33. For licence granted to sell by retail drugs, specified in schedule C and C(1) drugs from no. require is

a. 20B

b. 21

c. 21B

d. 20

34 / 50

34. Schedule J is related to

a. Pack sizes of drugs.

b. List of disease and ailments which drug cannot claim.

c. Curable disease

d. GMP

35 / 50

35. As per D & C Act “Schedule FF” is related with

a. Ophthalmic preparation

b. Skin cosmetic preparation

c. Parenteral preparation

d. Ointment formulation

36 / 50

36. The first edition of India Pharmacopoeia was published in the year :

a. 1955

b. 1950

c. 1940

d. 1985

37 / 50

37. Standard for mechanical contraceptive comes under Schedule ………………as per D & C Act

a. R1

b. R

c. S

d. O

38 / 50

38. Post marketing surveillance comes under clinical trial

a. Phase I

b. Phase III

c. Phase V

d. Phase II

39 / 50

39. Pack size of drug is covered under

a. Schedule P

b. Schedule P1

c. Schedule O

d. Schedule R

40 / 50

40. Insulin injection according to schedule P is should be stored

a. At temperature which not exceed 5°C

b. At the Temperature 2°C to 8°C and it must not allow to freeze

c. In cold place

d. At temperature which not exceed 20°C

41 / 50

41. Injection syringe and needles are covered under

a. Schedule B

b. Schedule A

c. Schedule P

d. Schedule Q

42 / 50

42. Which of the following is prohibited to be imported?

a. Misbranded drugs

b. Toilet preparations

c. Schedule ‘C’ ‘G’ drugs

d. Ayurvedic drugs

43 / 50

43. As per schedule P Carbenicillin Sodium Powder Should be Stored in/at

a. Temperature not exceeding 5°C

b. Well closed container, protect from light, in cool place, protect from light

c. A cool place

d. A Cold place

44 / 50

44. Aspirin sodium comes under

a. Schedule Y

b. Schedule G

c. Schedule H

d. Schedule J

45 / 50

45. The schedule in Drug and Cosmetics Act that deals with requirement and guidelines of clinical trial, import and manufacture of new drug is

a. Schedule O

b. Schedule F

c. Schedule Y

d. Schedule M

46 / 50

46. Schedule D as per D & C Act is concerned with

a. List of drug exempted from the provision of import of drugs

b. List of prescription drugs

c. Requirements of factory premises

d. Disease or ailments which a drug may not purport to prevent or cure

47 / 50

47. Pro-forma for sending memorandum is included in which schedule?

a. FF

b. A

c. Q

d. D

48 / 50

48. MCC is regulatory agency of ……………

a. Denmark

b. Brazil

c. UK

d. South Africa

49 / 50

49. Coca, opium and hemp come under:

a. Spurious Drug Act

b. Insecticide Act

c. Poisons Act

d. Dangerous Drug Act

50 / 50

50. Purpose of Phase-3 trial is

a. Efficacy and Safety of drug in longer number of patients (500 patients)

b. Long time adverse effects aster marketing drug

c. Determine Possible therapeutic uses, Effective doses range

d. To determine maximum tolerated dose in humans, Pharmacodynamics effects, Adverse effect.